Archive: 30/01/2019
Fexinidazole, the first all-oral treatment for sleeping sickness, approved in DRC
Marketing authorization of fexinidazole for the treatment of Trypanosoma brucei gambiense human African trypanosomiasis (HAT), more commonly known as sleeping sickness, has been granted in the Democratic Republic of Congo ...
Jan 30, 2019